Silk Road Medical
735 North Pastoria Avenue
28 articles with Silk Road Medical
Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Final Results Presented in Late-Breaking Session at Society for Vascular Surgery 2019 Vascular Annual Meeting
A summary of IPOs from companies in the biotech and pharma world since April 1, 2019.
A summary of IPOs from companies in the biotech and pharma world since March 1, 2019.
March has been a busy month for biopharma and medical device company initial public offerings. Here’s a look at the top IPO stories for the month.
One-Year Results of SVS TCAR Surveillance Project to be Featured
Silk Road Medical Announces Presentation of TCAR Data Demonstrating Favorable Outcomes in Patients with Carotid Artery Disease
First Large Body of Real World Clinical Evidence Showing Benefits of TCAR vs Surgery Presented at SVS 2018 Annual Meeting
Silk Road Medical Announces Key Events for Society for Vascular Surgery 2018 Vascular Annual Meeting
Silk Road Medical, Inc. announced key events at the upcoming Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM)
Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors.
The data from this year's VEITHsymposium add to the body of evidence supporting the use of Silk Road Medical's ENROUTE system.
Silk Road Medical Appoints World Class Stroke Prevention Champion To Serve As Vice President, Medical Affairs And Professional Education
Silk Road Medical Announces Updated Clinical Data On TCAR Presented At The 44th Annual VEITH Symposium
Silk Road Medical Announces New Medicare Coverage Option For TransCarotid Artery Revascularization (TCAR) Procedures
Silk Road Medical Announces Updated Clinical Data On TCAR Presented At The 2016 Society For Vascular Surgery Annual Meeting
Silk Road Medical Announces CE Mark Approval and First Patients Treated With the Next Generation ENROUTE Transcarotid Neuroprotection System
Silk Road Medical Release: First Patient Successfully Enrolled Into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study